Each year at the American Pancreas Association (APA) meeting, the conference opens with the Hirshberg Foundation Symposium. This year’s topic, pancreatic cancer cachexia, highlighted an important condition impacting many pancreatic […]
UCLA Scientists Develop Promising “Off-the-Shelf” CAR-NKT Cell Therapy for Pancreatic Cancer
The Hirshberg Foundation is committed to advancing the most innovative science with the potential to change outcomes for pancreatic cancer patients. UCLA is home to many of the nation’s leading […]
Progress Towards a Less Invasive Treatment for Pancreatic Neuroendocrine Tumors
Pancreatic neuroendocrine tumors, also called PNETs or PanNETs, are the second most common type of pancreatic cancer after pancreatic ductal adenocarcinomas or PDACs. While PDACs arise from ductal or exocrine […]
What is a Pancreatic Neuroendocrine Tumor?
Pancreatic neuroendocrine tumors, also called pNETs or PanNETs, are the second most common type of pancreatic tumor, representing up to 2% of all pancreatic cancer cases. pNETs are distinct from […]
Advancing the Field: Highlights from the 56th Annual APA Meeting
On November 12-15 2025, the American Pancreatic Association (APA) held their 56th annual meeting in San Diego, CA. This gathering brings together almost 500 clinicians and researchers from around the […]
Our 2025 UCLA Catalyst Grant Winners are Driving Research Towards Better Treatment Options
As we celebrate the 20th anniversary of our pioneering Seed Grant Program, we are proud to announce the launch of a new era in our mission to drive scientific breakthroughs: […]